Meet Our Speakers!
We have an amazing agenda of panelists. Here you can find their full bios.
Robert Galvin
MD
Dr. Robert Galvin is the Chief Executive Officer of Equity Healthcare (EH), which oversees the management of health care for firms owned by private equity companies. The focus is on using purchasing power to create innovative ways to achieve higher value health care, through improved population health, clinical quality and delivery system reforms. Currently, EH encompasses over 30 companies with healthcare spending exceeding $1.5B annually.
Before joining Blackstone as a Senior Advisor, Dr. Galvin was Executive Director of Health Services and Chief Medical Officer for General Electric (GE) for fifteen years, where he was in charge of the design, financial and clinical performance of GE’s health programs. He was also responsible for health policy strategies affecting employees. Dr. Galvin is a nationally recognized leader in the areas of market-based health policy and financing, quality measurement and payment reform.
His work has been widely published in the New England Journal of Medicine and Health Affairs and he was a co-founder of the Leapfrog Group and founder of two other groups, Bridges to Excellence and Catalyzing Payment Reform, all innovative non-profits that have helped drive the quality agenda. Dr. Galvin is a member of the Institute of Medicine and sits on the IOM’s Board on Health Care Services. He is also on the Board of Directors of the National Quality Forum and a member of the National Advisory Council for the Agency for Healthcare Research and Quality (AHRQ). Dr. Galvin is Professor Adjunct of Medicine and Health Policy at Yale. His work has received awards from the National Business Group on Health, the Healthcare Financial Management Association and the National Coalition for Cancer Survivorship. He is a fellow of the American College of Physicians.
Megan Ranney
MD, MPH, FACEP
Dr. Megan L. Ranney is an emergency physician, researcher, and leading advocate for innovative approaches to public health. She is the Dean of the Yale School of Public Health, the C.-E. A. Winslow Professor of Public Health, and a Professor of Emergency Medicine at Yale University. Under her leadership, the school is pursuing a bold new strategic vision of linking science and society, making public health foundational to communities everywhere. Her first-hand experiences as a member of the Peace Corps and a practicing physician have fueled her commitment to high-quality science.
She is a national leader in restarting the science of firearm injury prevention as a health issue. Her work on violence prevention, the use of technology to augment prevention, and the role of systems-level change in care has been published over 200 times. She is an elected member of the National Academy of Medicine and the Connecticut Academy of Science and Engineering, a Fellow of the American College of Emergency Physicians, and a member of the Aspen Global Leadership Network.
In addition to her scholarly work, she has harnessed social media to spark large public health movements, such as securing and distributing over 17 million units of donated PPE at the peak of the COVID-19 pandemic. She started two successful non-profits and serves as a board member on national and international organizations that work to use science to reduce firearm injury, improve science communication, and enhance emergency care, among other leadership roles. She has provided Congressional testimonies and other expertise to the U.S. Surgeon General and the White House across multiple presidential administrations. She is a sought-after media presence, with over 1,000 national and international appearances that translate public health messages and science for the public.
Before her Deanship at Yale, Dr. Ranney was previously the Warren Alpert Endowed Professor of Emergency Medicine, Deputy Dean of the School of Public Health, and Founding Director of the Brown-Lifespan Center for Digital Health at Brown University. Dr. Ranney earned her bachelor's degree in history of science, graduating summa cum laude from Harvard University; her medical doctorate, graduating Alpha Omega Alpha from Columbia University; and her master’s degree in public health from Brown University. She completed her residency in Emergency Medicine and a fellowship in Injury Prevention Research at Brown University.
Rachael Bedard
MD
Dr. Rachael Bedard is an internist, geriatrician and palliative care physician. She is also a contributing Opinion writer at The New York Times, and a Type Media fellow.
She doctors, teaches, writes and advocates at the intersections between health, ideas, politics and human rights. Her clinical work is primarily with homeless and justice-involved elders, especially people who are recurrently incarcerated in the final decades of their lives. From 2016-2022 she was a physician on Rikers Island. She currently sees patients at a safety net clinic in Brooklyn.
From 2023-2024, She sat on the New York City Board of Correction. From 2022-2024 she founded and ran an organization that supported the pro-choice side of state ballot initiatives.
Dr. Bedard studied History at Brown University and completed medical training at the Mount Sinai Hospital in New York and the Cambridge Health Alliance in Cambridge, Massachusetts.
Reed Tuckson
MD, FACP
Reed V. Tuckson, M.D., FACP, is Managing Director of Tuckson Health Connections, LLC, a vehicle to advance initiatives that support optimal health and wellbeing through the intersection of health promotion and disease prevention; applied data and analytics; enhanced quality and efficiency in care delivery; and the application of telehealth and biotech innovations.
​
Currently, Dr. Tuckson’s focus is on advancing his work as a co-founder of the Black Coalition Against COVID, a multi-stakeholder and interdisciplinary effort working to mitigate the COVID-19 pandemic in Washington,D.C. and nationally.
Previously, he enjoyed a long tenure as Executive Vice President and Chief of Medical Affairs for UnitedHealth Group, a Fortune 20 health and wellbeing company and has served as Senior Vice President for Professional Standards of the AMA; Senior Vice President of the March of Dimes Birth Defects Foundation; President of the Charles R. Drew University of Medicine and Science; and Commissioner of Public Health for the District of Columbia.
​
Dr Tuckson serves on the boards of Adverum Biotechnologies; CTI BioPharma; the Henry Schein Company and numerous not-for profit health boards, including Freedom House which is dedicated to advancing democracy throughout the world. ​A recognized leader in his field, Dr. Tuckson is honored to have been appointed to leadership roles at the National Institutes of Health; National Academy of Medicine; and numerous Federal Advisory Committees. He has been recognized several times by Modern Healthcare Magazine’s listing of the “50 Most Powerful Physician Executives” in health care. He is a graduate of Howard University, Georgetown University School of Medicine, and the Hospital of the University of Pennsylvania’s General Internal Medicine Residency and Fellowship Programs, where he was also a Robert Wood Johnson Foundation Clinical Scholar studying at the Wharton School of Business.
Farzad Mostashari
MS, ScM
Farzad Mostashari, M.D., ScM is the CEO of Aledade - the largest network of independent primary care practices in the country. Since founding Aledade in 2014, he has helped the company grow to serve over 3,000 practices in 48 states, accountable for the care of over 3 million patients.
Dr. Mostashari is the chair of the board of directors for Resolve to Save Lives, a global health organization focused on saving lives from cardiovascular disease and infectious disease epidemics, and is also Co-Chair of the Health Evolution Summit. He is the former National Coordinator for Health IT at the Department of Health and Human Services, and served as a distinguished expert at the Brookings Institute’s Engelberg Center for HealthCare Reform.
Dr. Mostashari received his MD from Yale University School of Medicine and his MPH from Harvard T.H. Chan School of Public Health.
Sejal Hathi
MD, MBA
Dr. Sejal Tyle Hathi is a board-certified physician and nationally recognized public health leader with more than 15 years of experience advancing physical and mental health, women's rights, and public policy in the United States and globally.
​
She serves as the 4th permanent Director of the Oregon Health Authority, appointed by Governor Tina Kotek and unanimously confirmed by the Oregon Senate to oversee all health care and public health services, policies, and programs for the State of Oregon. Most recently, she served as New Jersey's deputy health commissioner and state health officer — a position she held after two years as the Biden White House's Senior Policy Advisor for Public Health, where she led several presidential priorities across mental health, climate and health, public health preparedness, and supply chain policy. She has also held joint faculty appointments as an assistant professor of medicine at the Johns Hopkins School of Medicine & Bloomberg School of Public Health.
​
Dr. Hathi grew up in Fremont, California and received her B.S. with honors from Yale University and her M.D. / M.B.A. from Stanford University, where she studied as a Harry S. Truman Scholar and Paul & Daisy Soros Fellow. She completed her clinical training in internal medicine and primary care at Harvard Medical School and the Massachusetts General Hospital.
Reshma Ramachandran
MD, JD
Reshma Ramachandran, MD, MPP, MHS is a family medicine physician, health services researcher, and Assistant Professor within the Section of General Internal Medicine in the Department of Medicine at Yale University. She has published several peer-reviewed research articles and commentaries on the realignment of incentives for healthcare stakeholders including pharmaceutical companies, hospitals, and universities towards prioritizing equitable patient access to safe, effective health technologies. She co-directs the Yale Collaboration for Regulatory Rigor, Integrity, and Transparency (CRRIT), an interdisciplinary initiative aligning research on medical product evaluation, approval, and coverage with the goal of advancing policies that improve patient health and healthcare. Her research has led her to be invited to brief policymakers and testify before the U.S. Congress, including before the U.S. House of Representatives Committee on Energy and Commerce and Ways and Means Committee as well as the U.S. Senate Health, Education, Labor, and Pensions Committee.
Previously, Dr. Ramachandran was research faculty as part of the Innovation + Design Enabling Access (IDEA) Initiative at the Johns Hopkins Bloomberg School of Public Health. Dr. Ramachandran trained in both medicine at the Alpert Medical School at Brown University and in public policy at the Harvard Kennedy School of Government. She completed her family medicine residency at Kaiser Permanente Los Angeles Medical Center and fellowship training at the National Clinician Scholars Program at Yale University. She is a Reimagining America fellow with the Roosevelt Institute.
Jason Schwartz
PhD
Jason L. Schwartz is an Associate Professor in the Department of Health Policy and Management at the Yale School of Public Health. His research examines vaccines and vaccination policy, decision-making in medical regulation and public health policy, and the structure and function of scientific expert advice to government. The overall focus of his work is on the ways in which evidence is interpreted, evaluated, and translated into regulation and policy in medicine and public health. He holds a secondary appointment in the Section of the History of Medicine at the Yale School of Medicine and is affiliated with Yale's Institution for Social and Policy Studies and Program in the History of Science and Medicine.
His research, analysis, and perspectives have appeared in the New York Times, Washington Post, CNN, NPR, BBC, Time, and elsewhere. He has testified before the U.S. House Oversight Subcommittee on Economic and Consumer Policy, the National Vaccine Advisory Committee, and the Presidential Commission for the Study of Bioethical Issues. He is a fellow of The Hastings Center and a member of The Lancet Commission on Vaccine Acceptance in the United States, the New England Comparative Effectiveness Public Advisory Council for the Institute for Clinical and Economic Review (ICER), and the Board of Trustees of Saint Thomas More Catholic Chapel & Center at Yale.
​
During the COVID-19 pandemic, Schwartz was a member of Connecticut Gov. Ned Lamont's COVID-19 Vaccine Advisory Group and chair of its Science Subcommittee. He also advised colleges and universities, K-12 schools, early childhood centers, churches, and other organizations regarding their COVID-19 policies and protocols, particularly with respect to vaccines. Currently, he serves on the Advisory Committee to the Connecticut Commissioner of Public Health and the Board of Advisors for the Vaccine Integrity Project.
​
Prior to arriving at Yale, Schwartz was the Harold T. Shapiro Fellow at the Princeton University Center for Human Values, and earlier, an Associate Fellow and Lecturer in the Department of Medical Ethics and Health Policy at University of Pennsylvania Perelman School of Medicine. He was a staff member for President Barack Obama's Presidential Commission for the Study of Bioethical Issues.
Xiaoyan Huang
MD, MHCM, FACC, FACP
Xiaoyan Huang, YC '91, MD, MHCM, FACC is a cardiologist and Chief Medical Officer of the High Performing Network of Oregon. Dr. Huang graduated from Yale College, Stanford Medical School, and Harvard T. H. Chan School of Public Health. Having served as Chief of Clinical Cardiology at Providence Heart Institute and Medical Staff President, Dr. Huang’s work has focused on high value specialty care in the medical neighborhood. She has published on these topics in the New England Journal of Medicine, Circulation, Harvard Business Review, New England Journal of Medicine Catalyst, etc. Dr. Huang has also published on the broader topics of her personal journey as an immigrant in The Washington Post.
​
In gratitude to Yale, Dr. Huang spends much of her spare time volunteering for Yale. She is a past president of the award-winning Yale Club of Oregon and SW Washington. She has served on the board of the Yale Alumni Service Corp, YaleWomen Governing Council, Yale Alumni Magazine Advisory Board, and University Council. She is one of the founding administrators of the Yale Alumni Facebook Group, which now has over 22,900 alumni members. Since 2016, Dr. Huang has served on the Yale Alumni Association Board of Governors as a board member, chair of Volunteer Engagement, Alumni Fellow, Yale Medal, Volunteer Development Committees, as Executive Officer, Vice Chair, Chair, and currently the Immediate Past Chair. In 2026, Dr. Huang is serving as the global chair of Yale Day of Service.
Bhramar Mukherjee
PhD, MS
Professor Bhramar Mukherjee is the Anna M.R. Lauder Professor of Biostatistics and Professor of Chronic Disease Epidemiology at the Yale School of Public Health (YSPH). Professor Mukherjee serves as the inaugural Senior Associate Dean of Public Health Data Science and Data Equity at YSPH. She holds a secondary appointment in the Department of Statistics and Data Science and is affiliated with the MacMillan Center and the Institute for the Foundations of Data Science. She serves on the Yale Cancer Center Director’s cabinet.
Prior to joining Yale University in 2024, Dr. Mukherjee built a distinguished career at the University of Michigan from 2006-2024, where she was appointed as John D. Kalbfleisch Distinguished University Professor of Biostatistics (2023-2024), Siobán D. Harlow Collegiate Professor of Public Health (2023-2024), John D. Kalbfleisch Collegiate Professor of Biostatistics (2015-2023) and Chair of the Department of Biostatistics (2018-2024). She had several other significant leadership appointments at Michigan including an institutional appointment as the inaugural Assistant Vice President for Research for Research Data Services Strategy (2023-2024); Associate Director for Quantitative Data Sciences(2019-2024), Associate Director for Cancer Control and population Sciences (2015-2018) at the University of Michigan Rogel Cancer Center. She also held professorial appointments in Epidemiology and Global Public Health. Professor Mukherjee was actively engaged with the U-M Precision Health initiative, as well as the Michigan Institute of Data Science (MIDAS). She served as the founding director of a flagship undergraduate summer program in big data from 2015-2024. She has supervised twenty doctoral students and three post-doctoral fellows
Jan-Felix Schneider
MSc
Prathibha Varkey
MBBS, MBA
Prathibha Varkey is president of Mayo Clinic Health System (MCHS). As president, Dr. Varkey leads 17,000 employees serving 16 community hospitals and 53 multispecialty clinics across 44 communities in Minnesota, Wisconsin and Iowa. Dr. Varkey is also a Professor of Medicine and Preventive Medicine at Mayo Clinic College of Medicine and Science.
Prior to her current role, Dr. Varkey served as the Chief Executive Officer and President of the Yale New Haven Health Northeast Medical Group, and as the President and Chief Executive Officer of the Seton Clinical Enterprise. From 2001 to 2013, Dr. Varkey held leadership positions at Mayo Clinic in Rochester, including Associate Chair of the Department of Medicine; medical director of Ask Mayo Clinic; program director of the Preventive Medicine Fellowship, and Director of the Quality Improvement Curriculum.
A nationally recognized expert in Quality Improvement, Dr. Varkey is a past president of the American College of Medical Quality, has authored over 80 publications and is the editor of two books: Medical Quality Management and Mayo Clinic Board Review on Preventive Medicine and Public Health.
Luca Maini
PhD
Luca Maini, PhD, is an Assistant Professor of Health Care Policy at Harvard Medical School and a Research Fellow at the Cecil G. Sheps Center for Health Services Research. Before coming to the Department of Health Care Policy he was an Assistant Professor of Economics at the University of North Carolina at Chapel Hill.
Maini’s research focuses on competition and regulation in healthcare markets. His particular focus is on the pharmaceutical market, where he has studied the impact of price regulation that references prices across markets, the reaction of originator biologics to biosimilar entry, and the effect of M&A activity on the pricing and coverage of branded drugs. Maini received a BA in Economics and a BS in Mathematics from the University of Chicago, and his PhD in Economics from Harvard University.
Michael Hund
MBA
Michael Hund, MBA, is an award winning CEO with more than 20 years of experience in the innovative business models of venture philanthropy, impact investing and medtech entrepreneurship. His leadership has been highlighted by MIT, Yale, Harvard, Stanford, Cambridge, Forbes, and the Milken Institute.
He is the CEO of EB Research Partnership, a game changing medical research organization dedicated to curing EB and scaling their model to rare disease. Under his leadership EBRP has raised more than $80 million to transform the landscape from 2 to over 50 clinical trials and accelerated 3 FDA approved treatments in the last two years. He is Executive Producer of the award-winning Netflix documentary Matter of Time and Executive Producer of Venture into Cures, a movement combining stories of the patient and medical communities with musicians and actors. Previously he served as the Director for the Multiple Myeloma Research Foundation and Paul Newman’s Hole in the Wall Gang, working on behalf of children battling life threatening illnesses.
Michael received his MBA from Yale University, CORe credential from Harvard Business School, and a degree in Philosophy from the University of Kansas. He is the recipient of the MIT Solve Innovation Award, iHeart Media’s CEOs You Should Know, the Milken Institute’s Changemaker and LeadersLink, Social Innovations Journal Leadership Award, Top 100 Magazine Innovators, and IAOTP’s Top CEO of the Year in Medical Research.
Kasia Lipska
MD, MHS
Dr. Lipska is an endocrinologist at the Yale School of Medicine and a Clinical Investigator at the Yale-New Haven Hospital Center for Outcomes Research and Evaluation (CORE). Her research program seeks to better understand the balance of benefits and harms of glucose-lowering therapy in older adults with type 2 diabetes. Her current research projects are primarily focused on severe hypoglycemia. She is investigating trends in admissions for hypoglycemia among the elderly Medicare population; race, sex, and age disparities in these admissions; using qualitative research methods to explore reasons for hypoglycemia admissions; examining key risk factors for hypoglycemia; and developing prediction models for hypoglycemia. Based on these data, she seeks to develop and implement decision support tools to help clinicians and patients make better decisions about their care. Her overall goals are to generate data that patients and clinicians need—data which currently do not exist—so that they can make better, smarter treatment decisions.
​
In addition, Dr. Lipska works at CORE on the development of ambulatory care quality measures for the Centers for Medicare & Medicaid Services (CMS). She is currently leading the development of an outcome measure of care quality among people with diabetes mellitus.
Anup Sabharwal
MD, MBA, FACC, FACE, FESC, FAHA, FASPC, FNLA
Dr. Sabharwal, MD, MBA, is the Head of R&D and Scientific Strategy (VP), Cardiometabolic at Syneos Health, where he leads medical innovation and clinical development programs. A distinguished clinician-scientist, Dr. Sabharwal brings decades of expertise in cardiometabolic and endocrine diseases, with board certifications in endocrinology, diabetes, and metabolism. His leadership is focused on driving translational research and developing therapeutic strategies that bridge the gap between complex disease mechanisms and improved patient outcomes.
In his executive role, Dr. Sabharwal oversees strategic initiatives that shape study design and clinical trial execution. He partners with cross-functional teams to provide high-level medical-scientific advisory services, helping life sciences organizations accelerate the delivery of innovative therapies. His deep understanding of clinical evidence generation and medical strategy is instrumental in transforming clinical development to be more efficient and patient-centered.
Combining his clinical background with an MBA, Dr. Sabharwal offers a unique perspective on the intersection of healthcare delivery and business strategy. His career is dedicated to making therapies more effective and meaningful for patients worldwide through rigorous scientific leadership.
Nicola Hawley
PhD
Dr. Nicola Hawley is an Associate Professor of Epidemiology (Chronic Disease) at the Yale School of Public Health and holds a secondary appointment in the Department of Anthropology at Yale University. She also serves as Associate Director for Dissemination and Implementation Science at the Yale Center for Clinical Investigation. Trained as a human biologist, Dr. Hawley is an internationally recognized expert in maternal and child health, with particular expertise in the developmental origins of obesity and related chronic diseases.
Her interdisciplinary research bridges epidemiology, anthropology, and global health to examine how early life exposures—during pregnancy, infancy, and childhood—shape long-term health. She employs a life-course perspective and mixed-methods approaches across cross-sectional, cohort, and randomized controlled trial designs to identify critical windows for intervention. A hallmark of her work is the integration of community-engaged and culturally responsive strategies to address maternal and child health disparities in under-resourced and Indigenous settings.
​
While her primary research focus is on Pacific Islander communities in Samoa, American Samoa, and the US, Dr. Hawley has built long-standing collaborations in South Africa, Uganda, New Zealand, and the United States, contributing to global evidence on perinatal health, childhood growth, and intergenerational disease risk. Her current research portfolio includes NIH- and PCORI-funded studies addressing gestational and Type 2 diabetes, prevention of excess gestational weight gain, childhood obesity, and cardiometabolic risk across generations. She is also leading efforts to develop culturally grounded interventions that span pregnancy through adolescence, aiming to disrupt the intergenerational transmission of chronic disease. As a mentor, Dr. Hawley plays a central role in training the next generation of US and global health scientists, serving as primary mentor on multiple NIH career development awards (K01, K99, F30, F31) focused on Pacific Islander health.
Wendy Barr
MD, MPH, MSCE, FAAFP
Wendy B. Barr MD, MPH, MSCE, FAAFP is the Founding Residency Program Director for the Yale Family Medicine Residency Program at Lawrence + Memorial Hospital. She is dedicated to growing and strengthening the primary care workforce to equitably improve the health of communities. This guides her work in supporting and expanding family medicine training programs and research to inform how to best train the next generation of comprehensive personal physicians who provide excellent care to all patients.
​
Dr. Barr is a graduate of Tufts University School of Medicine MD/MPH program and completed her family medicine residency at the Lawrence Family Medicine Residency in Lawrence, MA. She then went on to complete a research and faculty development fellowship at the University of Pennsylvania School of Medicine where she also received a Masters of Science in Clinical Epidemiology. Dr. Barr is a Distinguished Scholar for the American Board of Family Medicine where she is conducting research on GME outcomes and GME program improvement and is the co-co-Principal Investigator for the Family Medicine Residency Outcome Project, and the ABFM Annual National Resident Survey.
​
Prior to coming to Yale, Dr. Barr was the Residency Program Director, ACGME Designated Institutional Officer (DIO), and Vice President of Clinical Education at the Greater Lawrence Family Health Center in Lawrence, MA where she helped to lead the family medicine residency program’s transition from a three year to four year curriculum as part of the national ACGME Length of Training Pilot and multiple other residency redesign and innovation initiatives. She has served on the Board of Directors of the Association of Family Medicine Residency Directors (AFMRD) from 2019-2023 including serving as President from 2021-2022 and she served on the Board of Directors for NAPCRG, an international primary care research professional association. She currently serves on multiple national family medicine education and research committees and taskforces. Her research interests include the care of pregnant people and children by family physicians, and developing evidence to support family medicine residency redesign and competency based medical education and board eligibility.
Bridget Basile
PhD, MA, RN, FNP-BC
Dr. Bridget Basile is a nurse-scientist with over a decade of clinical experience working as a family nurse practitioner providing primary care to underserved communities in urban and rural areas and a registered nurse in inpatient pediatric oncology and stem cell transplant. She also has experience caring for women and their families as a doula and certified breastfeeding specialist. Prior to entering nursing, she worked as an anthropologist on international development projects funded by agencies such as the World Bank and USAID. Dr. Basile holds a PhD from Yale University, an MSN from the University of California Los Angeles, a BSN from The Johns Hopkins University, and a BA and MA in Anthropology from Boston University. She completed an NIH-funded Rural Health Equity Postdoctoral Fellowship at the University of Minnesota School of Public Health.
Dr. Basile’s research aims to improve birth outcomes for women and birthing people marginalized by intersections of race, socioeconomic status, and geography by improving the experience and quality of perinatal care and interactions with the health system. Dr. Basile’s program of research has been supported by the Association for Women’s Health, Obstetric, and Neonatal Nurses, the March of Dimes, the Heilbrunn Family Center for Research Nursing at the Rockefeller University, the Institute for Advanced Study at the University of Minnesota, and the Health Equity Research Working Group at University of Minnesota School of Public Health.
Valerie Thomas
MA
Valerie is the Head of Patient Advocacy and Alliances at Comanche Biopharma where she is responsible for engaging advocacy groups and professional societies as well as cultivating strategic collaborations with key stakeholders. As a survivor of preeclampsia, Valerie is passionate about helping patients impacted by this condition and ensuring that the patient perspective is integrated into business decisions. With over 20 years of experience as a biopharmaceutical leader, Valerie has a breadth of experience in patient advocacy, alliance management, medical affairs, commercial operations, sales, and product launch excellence. She is recognized as a trusted collaborator with a record of cultivating strong relationships among key internal and external stakeholders across organizational levels to deliver solutions. Prior to joining Comanche Biopharma, Valerie held positions at Novartis, The Medicines Company, and Pfizer. Valerie holds a B.A. in Psychology from The College of Wooster and an M.A. in Higher Education Administration from Bowling Green State University.
Ingrid Katz
MD, MHS
Dr. Ingrid T. Katz is a nationally recognized physician-scientist and Director of the Yale Institute for Global Health. In this role, she leads the expansion of global health research, clinical, and educational initiatives across Yale. She holds a joint appointment in the Yale School of Medicine and Yale School of Public Health. Dr. Katz also serves as Chief of Evidence and Program Innovation in the Bureau of Global Health Security and Diplomacy at the U.S. Department of State.
Trained in infectious diseases, Dr. Katz’s global health expertise spans Southern Africa and Southeast Asia, where she has led federally funded initiatives focused on improving HIV care and advancing sustainable, equity-centered health interventions. For nearly 20 years, she has maintained NIH funding and long-term research partnerships with the University of Cape Town and the University of the Witwatersrand in South Africa. Her work has been recognized by UNAIDS and through her participation as an inaugural member of the Global Council on Inequality, AIDS, and Pandemics.
Prior to joining Yale, Dr. Katz spent 16 years on the faculty of Harvard Medical School and served as Associate Faculty Director at the Harvard Global Health Institute, where she co-led efforts addressing major global health threats, including the COVID-19 pandemic and the health impacts of climate change. She has also been deeply committed to mentorship and leadership development, helping to create and fund the LEAD Fellowship supporting women global health leaders from low- and middle-income countries. Her contributions have been recognized with the A. Clifford Barger Excellence in Mentoring Award and the Dean’s Award for an Emerging Leader in Women’s Careers. Dr. Katz earned her bachelor’s degree from Amherst College, a Master of Health Science from the Johns Hopkins Bloomberg School of Public Health, and her medical degree from the University of California, San Francisco.
Jennifer E. Miller
PhD
Jennifer E. Miller, PhD, is Co-Director of the Program for Biomedical Ethics and an Associate Professor in Yale School of Medicine. She is also the Director of the Good Pharma Scorecard (an index that ranks and rates pharmaceutical companies on their bioethical performance) and Founder of the nonprofit Bioethics International.
​
Her current research focuses on ethics, equity and governance in drug, vaccine, and medical device research, development, and accessibility as well as in the ethics of healthcare data sharing. She also specializes in developing and using metrics to enhance accountability and social responsibility in biomedical innovation.
​
Prior to joining Yale’s faculty, she was an Assistant Professor (tenure track) in NYU School of Medicine and completed training in physics, regulatory governance, bioethics, and ethics at Fordham University, Duke University, Regina Apostolorum Pontifical University, and Harvard University.
Sharon Chekijian
MD, MPH
Dr. Chekijian joined the Yale School of Medicine faculty in 2007 as an Associate Professor in the Department of Emergency Medicine. She is faculty member in the Section of Global Health and International Emergency Medicine as well as in the Section of Administration. She has served as inaugural Medical Director of patient experience since 2011. She served as the Medical Director of the Physician Assistant and Nurse Practitioner group in the Department of Emergency Medicine from 2007-2024. Dr. Chekijian is a seasoned educator and is the founding Medical Director of the APP post-graduate training program. She completed the Yale Medical Education Fellowship in 2014. At Yale School of Medicine she serves on the Executive Admissions Committee, the Educational Policy and Curriculum Committee and the Executive Committee of the Status of Women in Medicine.
​
Her research interests lie in global emergency medicine and include emergency care systems' development in low and middle-income countries, unintentional injury prevention in low and middle-income countries, as well as stroke and cardiac care in low and middle-income countries. Dr. Chekijian has led and participated in projects in the Republic of Armenia, Uganda, and Iraq. She has consulted for the World Bank and the US Department of State. She is an active member of the Stroke Initiative Advisory Task-Force for Armenia (SIATA).
In 2020, Dr. Chekijian was awarded a Fulbright for her work to improve emergency care in Armenia by the establishment of a new emergency medicine residency program in cooperation with the National Institutes of Health of Armenia and supported from a research standpoint by the School of Public Health at the American University of Armenia. In July of 2025 she was appointed founding Chair of the Department of Emergency Medicine and Disaster Medicine at the National Institute of Health of the Republic of Armenia.
​
She is the host of Yale Global Health Insights Podcast that seeks to understand the personal drive behind the people that are at the forefront of Global Health at Yale. Dr. Chekijian co-produced a film that addresses human rights as it relates to the Armenian Genocide of 1915 under the working title “The Hidden Map” that premiered at the Toronto Pomegranate Film Festival in 2019.
Peter Bach
MD
Health policy and payment expert, pulmonary physician, and lung cancer epidemiologist, Dr. Peter Bach has devoted his career to repairing defects in the healthcare delivery system that impede access to high-quality cancer care and working to ameliorate healthcares cost crisis. His work spans seminal studies including that identification of racial gaps in lung cancer care, the development of the first lung cancer risk prediction model (the Bach model), lead authorship on multiple lung screening guidelines, and definitional work on pharmaceutical pricing and value.
​
He currently as the Chief Medical Officer of Delfi Diagnostics and was previously an attending physician and researcher at Memorial Sloan-Kettering Cancer Center where he was the Director of the Center for Health Policy and Outcomes
Peter previously served as Senior Adviser at the US Centers for Medicare Medicaid Services and mentor on many National Institutes of Health K awards. He has been elected to the National Academy of Medicine, American Society for Clinical Investigation, and the Johns Hopkins Society of Scholars.
Cary Gross
MD
Cary Gross, MD, is a general internal medicine specialist who cares for adults with a wide range of medical needs. He focuses on improving outcomes for people with cancer and other chronic illnesses.
​
As a professor of medicine (general medicine) and of epidemiology (chronic diseases) at Yale School of Medicine, Dr. Gross investigates ways of delivering more patient-centered, effective cancer care. His research addresses comparative effectiveness, quality, and health equity, with a focus on cancer prevention and treatment. He aims to use real-world research to generate knowledge that will inform change in clinical care and health policy. He is a founding Director of Yale’s Cancer Outcomes Public Policy and Effectiveness Research Center (COPPER).
​
Dr. Gross completed his medical training at New York University School of Medicine, followed by residency in internal medicine at New York Hospital-Cornell Medical Center. He then served as chief medical resident at Memorial Sloan Kettering Cancer Center and pursued advanced training in outcomes research as a Robert Wood Johnson Foundation Clinical Scholar. Dr. Gross is program director for the National Clinician Scholars Program, a research-focused fellowship at Yale School of Medicine that aims to train the next generation of clinician scientists who will generate and use evidence to drive change in health care.
Chul S. Hyun
MD, PhD, MPH
Dr. Chul S. Hyun is a gastroenterologist and physician-scientist at Yale School of Medicine and the inaugural Director of the Gastric Cancer Prevention and Screening Program. His work focuses on prevention, early detection, and reducing disparities in gastric cancer through community-based approaches and migration-informed risk assessment, with an emphasis on policy-relevant solutions. He leads the Gastric Cancer Prevention Lab at Yale, advancing research at the intersection of clinical care, public health, and health equity.
​
Dr. Hyun received his B.S. from Johns Hopkins University and his M.D. from the University of Miami School of Medicine. He completed his Internal Medicine training at Georgetown University Medical Center and a Gastroenterology and Liver Fellowship at Yale University School of Medicine. He holds a Ph.D. in Biophysics from the University of Rochester School of Medicine and an MPH from Columbia University, and completed postdoctoral training in Physiology at the University of Chicago School of Medicine.
Dawn Mattoon
PhD
Dr. Dawn Mattoon is the Chief Executive Officer at Mercy BioAnalytics. She brings nearly 20 years of experience in the biotechnology industry and has held leadership positions in R&D, Strategy, and General Management for a series of exceptional companies including Invitrogen, Life Technologies, Thermo Fisher, and Cell Signaling Technology.
Prior to joining Mercy, Dr. Mattoon served as the Senior Vice President for Clinical Diagnostics at Quanterix, where she led the development and commercialization of the company’s first two FDA authorized diagnostic tests for COVID-19, and received Breakthrough Device designations from the FDA for diagnostic tests in Alzheimer’s Disease and Multiple Sclerosis. She has developed and commercialized products across a range of proteomic and genomic technologies and is thrilled by the opportunity to bring the highly innovative Mercy Halo diagnostic test portfolio to patients.
Dr. Mattoon earned her Ph.D. in Genetics with a focus in signal transduction from Yale University, where she also completed her postdoctoral fellowship.
Colleen Fitzpatrick
MD
Dr. Colleen M. Fitzpatrick, MD, MPA, is a board-certified pediatric surgeon at Northwell Health and an Associate Professor at the Zucker School of Medicine at Hofstra University. A former US Air Force Lieutenant Colonel and Surgeon-in-Chief at Cardinal Glennon Children’s Hospital, she now serves as Chief of Pediatric Surgery at South Shore University Hospital while specializing in healthcare sustainability.
​
Transitioning into academic medicine, Dr. Fitzpatrick held prestigious positions at St. Louis University, including Associate Professor, Pediatric Surgery Division Chief, and Surgeon-in-Chief at Cardinal Glennon Children’s Hospital. Her commitment to global health and service is further evidenced by her work with Doctors Without Borders in Liberia and her frontline service in a New York ICU during the initial wave of the COVID-19 pandemic. These diverse experiences in trauma and pediatric surgery have shaped her holistic approach to healthcare and leadership.
​
A passionate champion for the environment, Dr. Fitzpatrick earned an MPA in Environmental Policy and Sustainability Management from Columbia University (SIPA). She is an active leader in the greening of healthcare, serving as co-chair of Healthcare Without Harm’s Surgeons for a Sustainable Future and a member of the Northwell Health Clinical Sustainability working group. Her current initiatives focus on Life Cycle Analysis, transitioning to reusable surgical textiles, and integrating sustainability into medical school curricula to empower the next generation of physicians
Shalini Shah
DO
Shalini H. Shah, DO is a practicing board-certified pediatrician, environmental medicine physician, and assistant director for the Boston Children’s Pediatric Environmental Health Center (PEHC) and Region I Pediatric Environmental Health Specialty Unit (PEHSU). She completed her residency in pediatrics at the University of Massachusetts Medical School and her fellowship in pediatric and reproductive environmental health at Boston Children's Hospital.
​
Dr. Shah provides clinical care in primary care pediatrics and environmental health clinic for patients with environmental exposures. She is passionate about the intersection of the climate crisis, environmental justice, and children’s health. Her research and academic efforts are aimed at bringing environmental health to the "bedside" via development of an environmental health screening tool that is integrated into clinical care to bolster referrals and resource utilization by families. Other projects she is working on include developing patient-facing materials on how climate change impacts health and sharing what families can do to prepare/adapt, as well as the development of a continuing education curriculum and quality improvement project to help pediatric providers integrate climate counseling into clinical care. Her work has been presented both regionally and nationally.
​
Dr. Shah has additional roles as co-director for the Environmental Justice and Climate Change Scholars program hosted by the Region I PEHSU, national climate advocate for the Massachusetts Chapter of the American Academy of Pediatrics, and serves as the co-chair for the Academic Pediatrics Association Environmental Health, Climate Change, and Sustainability SIG.
Muoi A. Trinh
MD
Muoi A. Trinh, MD, is an Associate Professor in the Department of Anesthesiology and Perioperative Pain Medicine at the Icahn School of Medicine at Mount Sinai and serves as Medical Director of Environmental Sustainability for the Mount Sinai Health System (MSHS). In this role, she has led systemwide initiatives that position Mount Sinai as a national leader in health care decarbonization.
​
A recognized expert on sustainability in perioperative medicine, Dr. Trinh has advanced the integration of environmental stewardship into clinical care and operational strategy. She has spearheaded comprehensive efforts to measure and reduce greenhouse gas emissions across all three reporting scopes—developing actionable strategies to curb emissions from anesthetic gases, energy use, and the health care supply chain. Her leadership has driven measurable, high-impact reductions across the system.
​
Dr. Trinh serves on the MSHS Executive Committee on Sustainability, advancing alignment with major public commitments, including the New York City Carbon Challenge and the New York State Insurance Fund Climate Action Pledge. Under her leadership, Mount Sinai has earned multiple Environmental Excellence Awards from Practice Greenhealth. Through strategic vision, interdisciplinary collaboration, and evidence-based advocacy, Dr. Trinh is shaping a health care delivery model that prioritizes planetary health alongside patient care.
Scott LaRue
MBA, RD
For more than a decade, Scott LaRue has served as president and CEO of ArchCare, the non-profit healthcare system of the Archdiocese of New York. Under his leadership, the organization has evolved into one of the nation’s largest Catholic healthcare ministries, growing from a traditional nursing home provider into a dynamic continuum of care. Today, ArchCare’s 4,400 members serve over 10,000 people daily through skilled nursing, home care, hospice, and specialized programs for complex health needs.
​
LaRue has spearheaded over $200 million in capital improvements and successfully navigated the system through the COVID-19 pandemic with significant investments in infectious disease prevention. His tenure is marked by innovative expansions, including the opening of the Center for Advanced Memory Care and the growth of the Senior Life PACE program. As a leading advocate for the PACE model, which delivers nursing-home-level care to elders at home, LaRue now chairs the New York State PACE Alliance.
​
A Registered Dietitian with an MBA from Syracuse University, LaRue brought extensive leadership experience from Loretto in Upstate New York before joining ArchCare in 2007. Beyond his role as CEO, he is an active member of the Greater New York Hospital Association and serves on the New York State Public Health and Health Planning Council. His career remains dedicated to expanding access and improving the quality of care for New York’s most vulnerable populations.
Alexi Nazem
MD, MBA
Alexi Nazem, MD, MBA, is a General Partner leading the Healthcare team at AlleyCorp, where he oversees investments and incubations across healthcare technologies and services. Prior to AlleyCorp, Alexi co-founded Nomad Health, a digital marketplace for clinical talent, where he served as the company’s CEO for nine years.
Alexi is also a Clinical Assistant Professor of Medicine at Weill Cornell. Previously, he was a part of the leadership team of the 100,000 Lives Campaign at the Institute for Healthcare Improvement. Board-certified in Internal Medicine, Alexi previously practiced at New York Presbyterian Hospital and completed residency at Harvard’s Brigham and Women’s Hospital. He graduated from Yale University, earning an MD from the Yale School of Medicine and an MBA at Harvard Business School.
